TopFunds

GE HealthCare

NASDAQ: GEHC

Stock price

64.22 USD

(+0%) TODAY

Health Care EquipmentMedical - Healthcare Information Services
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
3.4
4.4
4.9
4.2
3
4.3
4.6
5.2%
02Free cash flow per share
3.6
3.1
3
4
3.7
3.4
3.3
(1.8)%
03Dividends per share
-
-
-
-
0.1
0.1
0.1
24.7%
04Dividends payout, %
-
-
-
-
2.6%
2.8%
3.1%
8.4%
PROFIT AND LOSS STATEMENT
05Revenue
16,633
17,164
17,585
18,341
19,552
19,672
20,625
3.7%
06% Change
-
-
-
-
-
-
-
3.7%
07Cost of revenue
(10,085)
(10,397)
(10,411)
(11,162)
(11,630)
(11,467)
(12,378)
3.5%
08Gross profit
6,548
6,767
7,174
7,179
7,922
8,205
8,247
3.9%
09% Margin
39.4%
39.4%
40.8%
39.1%
40.5%
41.7%
40%
40.1% A
10Operating expenses
(4,424)
(4,047)
(4,379)
(4,657)
(5,487)
(5,580)
(5,485)
3.7%
11% of Revenue
(26.6)%
(23.6)%
(24.9)%
(25.4)%
(28.1)%
(28.4)%
(26.6)%
(26.2)% A
12Operating Income
2,124
2,720
2,795
2,522
2,435
2,625
2,762
4.5%
13Income tax expense
(410)
(652)
(600)
(563)
(743)
(531)
(614)
7%
14Net Income
1,524
13,846
2,247
1,916
1,568
1,993
2,084
5.4%
15% Margin
9.2%
80.7%
12.8%
10.5%
8%
10.1%
10.1%
20.2% A
16Shares Outstanding
454.7
454.7
454.7
453.9
458
459
460.3
0.2%
17EPS Basic
3.4
4.4
4.9
4.2
3
4.4
4.6
5.3%
18EPS Diluted
3.4
4.4
4.9
4.2
3
4.3
4.6
5.2%
19EBITDA
2,838
3,406
3,540
3,165
3,513
3,666
3,785
4.9%
% Margin
17.1%
19.8%
20.1%
17.3%
18%
18.6%
18.4%
18.5% A
20Net Interest Income (expense)
(52)
(17)
(6)
(86)
(516)
(505)
(450)
43.3%
21Net Debt / EBITDA
-
(0.2)
-
2.3
2.1
1.8
1.5
1.2 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
-
1,007
556
1,445
2,504
2,890
4,512
35%
23Short-term investments
-
-
-
-
-
-
-
-
24Accounts receivable
-
2,657
3,791
3,993
4,315
4,376
3,955
8.3%
25Other current assets
-
190
250
226
231
311
-
13.1%
26Inventory
-
1,594
1,946
2,155
1,960
1,939
2,234
7%
27Total Current Assets
-
5,448
6,543
7,819
9,010
9,516
10,701
14.5%
Non-Current Assets
28Net property, plant & equipment
-
2,202
2,235
2,314
2,500
2,550
3,092
7%
29Long-term investments
-
709
665
663
733
804
-
3.2%
30Other non-current assets
-
15,869
16,865
16,743
20,211
20,219
19,110
3.8%
31Total Non-Current Assets
-
18,780
19,765
19,720
23,444
23,573
22,202
3.4%
Total Assets
-
24,228
26,308
27,539
32,454
33,089
36,906
8.8%
LIABILITIES
Current Liabilities
32Accounts payable
-
2,387
2,729
3,090
2,947
3,022
3,250
6.4%
33Short-term debt
-
132
110
119
1,116
1,617
508
30.9%
34Other current liabilities
-
4,005
3,922
3,982
4,918
4,914
5,347
6%
35Total Current Liabilities
-
6,524
6,761
7,191
8,981
9,553
9,105
6.9%
Non-Current Liabilities
36Long-term debt
-
336
327
8,516
8,747
7,759
9,495
95.1%
37Other non-current liabilities
-
2,394
2,324
2,240
7,416
7,124
7,707
26.3%
38Total Non-Current Liabilities
-
2,730
2,651
10,756
16,163
14,883
17,202
44.5%
39Total Liabilities
-
9,254
9,412
17,947
25,144
24,436
26,307
23.2%
SHAREHOLDERS` EQUITY
40Common stock
-
-
17,692
11,235
5
5
5
(87)%
41Retained earnings / (deficit)
-
-
-
-
1,326
3,262
5,281
99.6%
42Accumulated other comprehensive income / (loss)
-
14,727
(1,037)
(1,878)
(691)
(1,379)
(1,388)
-
43Noncontrolling interests
-
247
241
235
177
206
220
(2.3)%
44Total shareholders' equity
-
14,974
16,896
9,592
7,310
8,653
10,599
(6.7)%
45Total Liabilities and shareholders' Equity
-
24,228
26,308
27,539
32,454
33,089
36,906
8.8%
46Total Debt
-
468
437
8,635
9,863
9,376
10,003
84.5%
47Net Debt
-
(539)
(119)
7,190
7,359
6,486
5,491
-
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
1,524
13,846
2,247
1,916
1,568
1,993
2,084
5.4%
49Depreciation & amortization
659
630
625
633
610
580
578
(2.2)%
50Share-based compensation expense
-
-
76
67
114
125
130
14.4%
51Changes in working capital and other assets
(194)
(12,789)
(1,341)
(503)
(191)
(747)
(804)
26.7%
52Net cash flows from operating activities
1,989
1,687
1,607
2,113
2,101
1,951
1,988
(0)%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(263)
(237)
(248)
(310)
(387)
(401)
(482)
10.6%
54Purchases of investments / marketable securities
-
-
-
(59)
(48)
(40)
(118)
26%
55Proceeds from maturities of marketable securities
-
-
-
-
-
-
-
-
56Other investing activities
(62)
20,223
(1,513)
(29)
(123)
(473)
(447)
39%
57Net cash flows from investing activities
(325)
19,986
(1,761)
(398)
(558)
(914)
(1,047)
21.5%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
-
-
-
-
-
33
(163)
-
59Dividends paid, net
-
-
-
-
(41)
(55)
(64)
24.9%
60Debt issuance (repayments), net
(59)
(16)
(12)
8,204
1,139
(423)
967
-
61Other financing activities
(1,515)
(21,528)
(251)
(9,026)
(1,576)
(128)
(123)
(34.2)%
62Net cash flows from financing activities
(1,574)
(21,544)
(263)
(822)
(478)
(573)
617
-
63Increase (decrease) in cash and cash equivalents
35
143
(451)
890
1,055
387
1,622
89.5%
64Cash and equivalents, ending balance
869
1,012
561
1,451
2,506
2,893
4,515
31.6%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
1,726
1,450
1,359
1,803
1,714
1,550
1,506
(2.3)%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022

GE HealthCare (GEHC) financial statements and performance

Explore GE HealthCare (GEHC) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.